Company Overview - Vivos Therapeutics, Inc. held its 2025 Annual Meeting of Stockholders via live webcast, emphasizing the shift towards virtual meetings for improved accessibility and attendance [1][3]. Leadership and Structure - Kirk Huntsman serves as the Chief Executive Officer and Chairman of the Board of Directors, with Brad Amman acting as Chief Financial Officer and Secretary of the meeting [2]. Voting and Participation - Stockholders of record as of September 8, 2025, are eligible to vote either by proxy or virtually during the meeting, allowing for greater participation [3]. - Shareholders who have already submitted a proxy and do not wish to change their vote are not required to vote again, streamlining the voting process [4].